NYSE Arca · IBO
Impact BioMedical, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for IBO: Nov 6, 2026
Impact BioMedical, Inc. Common Stock is estimated to report earnings on 11/06/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-1.52.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative- RTTNews · Sep 16, 10:17 AM EDTImpact Biomedical Files Form F-4 For Proposed Zoar Business Combination(RTTNews) – DSS, Inc. (DSS), a significant stockholder of Impact Biomedical Inc. (IBO), announced that Zoar Limited has filed a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (SEC) in connection with the previously announced proposed business
- RTTNews · Sep 15, 4:30 AM EDTImpact Biomedical Issues Correction On Merger Exchange Ratio As Reverse Stock Split Takes Effect(RTTNews) – Impact Biomedical Inc. (IBO) has issued a corrected update to its previously released merger announcement, clarifying that one Zoar Limited share for each Impact share held immediately prior to the merger's effective time after giving effect to the reverse stock split
- RTTNews · Sep 14, 5:36 AM EDTImpact BioMedical Announces Reverse Stock Split To Advance Merger With Zoar Ltd.(RTTNews) – Impact BioMedical Inc. (IBO) announced on Friday that it will implement a 1-for-12.62 reverse stock split as part of its plan to complete a proposed merger with Zoar Ltd., a transaction aimed at creating a combined company with expanded manufacturing and clinical deve
- RTTNews · Mar 5, 9:25 AM ESTImpact BioMedical Shares Surge Over 115% On Amended Merger And Share Exchange Agreement(RTTNews) – Impact BioMedical, Inc (IBO) is trading sharply higher in pre-market up nearly 115%, after the company filed a new Form 8-K detailing amendments to its merger-related agreement.
- RTTNews · Jun 23, 11:42 AM EDTDr Ashleys To Acquire Impact BioMedical In Reverse Merger, IBO Shares Surge(RTTNews) – Dr Ashleys Ltd. and Impact BioMedical Inc. (IBO) announced Monday the signing of a definitive merger agreement under which Dr Ashleys will acquire Impact BioMedical via a reverse merger, creating a new public company to be listed on the NYSE American under the name 'D
- Quiver Quantitative · Jun 23, 8:00 AM EDTDr Ashleys Limited and Impact BioMedical Announce Strategic Merger to Enhance Pharmaceutical InnovationsDr Ashleys and Impact BioMedical announce a merger to enhance market reach and accelerate development of innovative pharmaceuticals.
- Quiver Quantitative · Mar 24, 8:15 PM EDTInsider Sale: 10% owner at $IBO Sells 53,280 SharesINC. DSS,, a 10% owner of $IBO, sold 53,280 shares of the company on 03-20-2025 for an estimated $249,350. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Impact BioMedical, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.